Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...

Popular weight-loss drug Wegovy maker Novo Nordisk expects high demand and acceptance for its anti-obesity drug, when ...

The following chart lists examples of mild ... In addition, the American Diabetes Association’s treatment guidelines recommend GLP-1 agonists (the drug class Ozempic and Victoza belong to ...

branded as Mounjaro for diabetes and Zepbound for weight loss. The products, members of the extremely popular and effective class of GLP-1 drugs, had been on the shortage list since December 2022.

The lowest dose of Novo Nordisk's weight-loss drug, Wegovy, was listed as available on the U.S. health regulator's website on Wednesday.

The class originally was designed to treat diabetes but it subsequently ... That demand in turn sent the value of the drug class soaring, with the list price for the medications reaching more ...

The findings add to a growing list of other health benefits researchers are studying related to the medications, which target ...